Algert Global’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,701
| Closed | -$7.88M | – | 1378 |
|
|
2025
Q1 | $7.88M | Buy |
59,701
+34,840
| +140% | +$4.6M | 0.19% | 142 |
|
|
2024
Q4 | $2.08M | Sell |
24,861
-20,489
| -45% | -$1.71M | 0.05% | 596 |
|
|
2024
Q3 | $3.32M | Sell |
45,350
-20,990
| -32% | -$1.54M | 0.09% | 398 |
|
|
2024
Q2 | $4.54M | Sell |
66,340
-64,271
| -49% | -$4.4M | 0.15% | 202 |
|
|
2024
Q1 | $9.04M | Buy |
130,611
+51,001
| +64% | +$3.53M | 0.35% | 45 |
|
|
2023
Q4 | $5.7M | Buy |
79,610
+4,260
| +6% | +$305K | 0.23% | 110 |
|
|
2023
Q3 | $3.93M | Sell |
75,350
-14,124
| -16% | -$736K | 0.18% | 170 |
|
|
2023
Q2 | $5.67M | Buy |
+89,474
| New | +$5.67M | 0.25% | 91 |
|
|
2022
Q3 | – | Sell |
-4,301
| Closed | -$246K | – | 1363 |
|
|
2022
Q2 | $246K | Buy |
+4,301
| New | +$246K | 0.02% | 967 |
|